Arkolith/Insider Trading/CYTK/Form 4

Blum Robert I

President & CEO, DirectorCYTOKINETICS INC (CYTK) · full profile →Form 4 · filed Jul 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$615K
Net Open-Market Flow
-$615K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 13, 2026Sell(S)10$82.02$820378K
Jul 13, 2026Option exercise(M)7K$10.60$79K385K
Jul 13, 2026Sell(S)7K$82.02$614K378K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)7K—$0187K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001061983-26-000077) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML